Vinflunine in the treatment of advanced urothelial cancer: clinical evidence and experience.

about

Vinflunine in the treatment of advanced urothelial cancer: clinical evidence and experience.

Item

http://www.wikidata.org/entity/Q37514607

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Vinflunine in the treatment of ...... nical evidence and experience.

@en

Vinflunine in the treatment of ...... nical evidence and experience.

@nl

type

Item

label

Vinflunine in the treatment of ...... nical evidence and experience.

@en

Vinflunine in the treatment of ...... nical evidence and experience.

@nl

prefLabel

Vinflunine in the treatment of ...... nical evidence and experience.

@en

Vinflunine in the treatment of ...... nical evidence and experience.

@nl

P1476

Vinflunine in the treatment of ...... nical evidence and experience.

@en

P2093

Claus-Henning Köhne

http://www.w3.org/2001/XMLSchema#string

Friedhelm Wawroschek

http://www.w3.org/2001/XMLSchema#string

Holger Gerullis

http://www.w3.org/2001/XMLSchema#string

Thorsten Holger Ecke

http://www.w3.org/2001/XMLSchema#string

P2860

Monotherapy with intravenous vinflunine in patients with advanced or metastatic urothelial cancer after failure of a platinum-containing regimen: a retrospective analysis of German routine data.

Vinflunine in routine clinical practice for the treatment of advanced or metastatic urothelial cell carcinoma - data from a prospective, multicenter experience.

Combined treatment with pazopanib and vinflunine in patients with advanced urothelial carcinoma refractory after first-line therapy.

Vinflunine, the latest Vinca alkaloid in clinical development. A review of its preclinical anticancer properties.

Safety and effectiveness of vinflunine in patients with metastatic transitional cell carcinoma of the urothelial tract after failure of one platinum-based systemic therapy in clinical practice.

Antimitotic and tubulin-interacting properties of vinflunine, a novel fluorinated Vinca alkaloid.

Phase III trial of vinflunine plus best supportive care compared with best supportive care alone after a platinum-containing regimen in patients with advanced transitional cell carcinoma of the urothelial tract.

How to manage intravenous vinflunine in cancer patients with renal impairment: results of a pharmacokinetic and tolerability phase I study.

Docetaxel As Monotherapy or Combined With Ramucirumab or Icrucumab in Second-Line Treatment for Locally Advanced or Metastatic Urothelial Carcinoma: An Open-Label, Three-Arm, Randomized Controlled Phase II Trial.

Efficacy and safety of Vinflunine for advanced or metastatic urothelial carcinoma in routine practice based on the French multi-centre CURVE study.

P304

28-35

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1756287216677903

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28042310

http://www.w3.org/2001/XMLSchema#string

P932

5167074

http://www.w3.org/2001/XMLSchema#string